Guanabenz
From Self-sufficiency
Revision as of 07:05, 20 March 2010 by حسن علي البط (Talk) (Quick-adding category Organochlorides (using HotCat))
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
| File:Guanabenz.svg | |
| File:Guanabenz sf.png | |
| Systematic (IUPAC) name | |
|---|---|
|
2-(2,6-dichlorobenzylidene)hydrazinecarboximidamide | |
| Clinical data | |
| Pregnancy category |
|
| Pharmacokinetic data | |
| Protein binding | 90% |
| Biological half-life | 6 hours |
| Identifiers | |
| CAS Number | 5051-62-7 |
| ATC code | none |
| PubChem | CID 3517 |
| DrugBank | APRD00487 |
| Chemical data | |
| Formula | C8H8Cl2N4 |
| Molar mass | 231.081 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
| (verify) | |
Guanabenz (pronounced GWAHN-a-benz, sold under the trade name Wytensin) is an alpha agonist of the alpha-2 type that is used as an antihypertensive drug. It is used to treat high blood pressure (hypertension).
The most common side effects during guanabenz therapy are dizziness, drowsiness, dry mouth, headache and weakness.
Guanabenz can make one drowsy or less alert, therefore driving or operating dangerous machinery is not recommended.
| 40px | This antihypertensive-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- 2Fix
- Guanidines
- Alpha-adrenergic agonists
- Organochlorides
- Antihypertensive agent stubs
